This company listing is no longer active
Calliditas Therapeutics Dividend
Dividend criteriumcontroles 0/6
Calliditas Therapeutics does not have a record of paying a dividend.
Belangrijke informatie
n/a
Dividendrendement
n/a
Uitbetalingsratio
Gemiddelde opbrengst industrie | 2.2% |
Volgende betaaldatum dividend | n/a |
Ex-dividenddatum | n/a |
Dividend per aandeel | n/a |
Winst per aandeel | -US$8.89 |
Dividendrendementsvoorspelling | 0% |
Recente dividendupdates
Geen updates
Recent updates
Asahi Kasei To Pay A Fair Price For Calliditas Therapeutics
May 28Calliditas Therapeutics GAAP EPS of -SEK 3.62, revenue of SEK 64M
Aug 18Calliditas Therapeutics wins European approval for Kinpeygo for IgA nephropathy
Jul 15Calliditas submits nefecon marketing authorisation application to the EMA
May 28Calliditas shares rise 10% as FDA grants priority review for Nefecon
Apr 28Calliditas Therapeutics reports Q3 results
Nov 12Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: Insufficient data to determine if CALT's dividends per share have been stable in the past.
Groeiend dividend: Insufficient data to determine if CALT's dividend payments have been increasing.
Dividendrendement versus markt
Calliditas Therapeutics Dividendrendement versus markt |
---|
Segment | Dividendrendement |
---|---|
Bedrijf (CALT) | n/a |
Markt onderkant 25% (US) | 1.4% |
Markt Top 25% (US) | 4.4% |
Gemiddelde industrie (Pharmaceuticals) | 2.2% |
Analist prognose (CALT) (tot 3 jaar) | 0% |
Opmerkelijk dividend: Unable to evaluate CALT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Hoog dividend: Unable to evaluate CALT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Winstuitkering aan aandeelhouders
Verdiendekking: Insufficient data to calculate CALT's payout ratio to determine if its dividend payments are covered by earnings.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Unable to calculate sustainability of dividends as CALT has not reported any payouts.